Indications & Dose:
Amenorrhea (primary and secondary), dysfunctional uterine bleeding, metrorrhagia, metastatic endometrial carcinoma (palliative therapy). Threatened abortion, habitual abortion.
DOSAGE
Adult
Usual dose 250-500mg weekly during 1st half of the pregnancy.
Amenorrhea and uterine bleeding: IM 375 mg, repeated q4 wk prn
Endometrial carcinoma: IM 1-7 g/wk
Habitual abortion: After confirmation of pregnancy, 250-500mg IM at weekly intervals.
Threatened abortion: 500mg IM 2-3 times weekly.
Contraindications:
Active thromboembolic disorders or thrombophlebitis, cerebral hemorrhage, impaired liver function or disease, breast cancer, undiagnosed vaginal bleeding, missed abortion, use as a diagnostic test for pregnancy
Side Effects:
CNS: Depression, dizziness, fatigue, headache
CV: Edema
GI: Anorexia, cholestatic jaundice, increased weight, nausea, vomiting
GU: Amenorrhea, breakthrough bleeding, breast changes, dysmenorrhea, gynecomastia
METAB: Hyperglycemia
SKIN: Acne, alopecia, hirsutism, melasma, rash
Cautions:
Precautions:
Epilepsy, migraine, asthma, cardiac or renal dysfunction, depression, diabetes
Interaction:
Drugs
Aminoglutethimide: Decreases progestin concentration
Warnings:
Adverse Effects:
Lactations:
Pregnancy category D: an increased risk of hypospasdias in the male fetus and mild virilization of the female fetus have been reported with progestin use; progestins compatible with breast feeding
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team